154 related articles for article (PubMed ID: 22993634)
1. Genomic and in vivo evidence of synergy of a herbal extract compared to its most active ingredient: Rabdosia rubescens vs. oridonin.
Wong AM; Zhang Y; Kesler K; Deng M; Burhenn L; Wang D; Moro A; Li Z; Heber D
Exp Ther Med; 2010 Nov; 1(6):1013-1017. PubMed ID: 22993634
[TBL] [Abstract][Full Text] [Related]
2. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
[TBL] [Abstract][Full Text] [Related]
3. Oridonin inhibits aberrant AKT activation in breast cancer.
Sun B; Wang G; Liu H; Liu P; Twal WO; Cheung H; Carroll SL; Ethier SP; Mevers EE; Clardy J; Roberts T; Chen C; Li Q; Wang L; Yang M; Zhao JJ; Wang Q
Oncotarget; 2018 May; 9(35):23878-23889. PubMed ID: 29844859
[TBL] [Abstract][Full Text] [Related]
4. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.
Hsieh TC; Wijeratne EK; Liang JY; Gunatilaka AL; Wu JM
Biochem Biophys Res Commun; 2005 Nov; 337(1):224-31. PubMed ID: 16176802
[TBL] [Abstract][Full Text] [Related]
5. Oridonin Suppresses Human Gastric Cancer Growth in Vitro and in Vivo via Inhibition of VEGF, Integrin β3, and PCNA.
Yang Q; Ma W; Yu K; Zhang Q; Ye Z; Xia W; Li S
Biol Pharm Bull; 2020; 43(7):1035-1045. PubMed ID: 32612067
[TBL] [Abstract][Full Text] [Related]
6. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways.
Ikezoe T; Yang Y; Bandobashi K; Saito T; Takemoto S; Machida H; Togitani K; Koeffler HP; Taguchi H
Mol Cancer Ther; 2005 Apr; 4(4):578-86. PubMed ID: 15827331
[TBL] [Abstract][Full Text] [Related]
7. The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells.
Ren KK; Wang HZ; Xie LP; Chen DW; Liu X; Sun J; Nie YC; Zhang RQ
J Ethnopharmacol; 2006 Jan; 103(2):176-80. PubMed ID: 16169170
[TBL] [Abstract][Full Text] [Related]
8. Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma
Song M; Liu X; Liu K; Zhao R; Huang H; Shi Y; Zhang M; Zhou S; Xie H; Chen H; Li Y; Zheng Y; Wu Q; Liu F; Li E; Bode AM; Dong Z; Lee MH
Mol Cancer Ther; 2018 Jul; 17(7):1540-1553. PubMed ID: 29695636
[TBL] [Abstract][Full Text] [Related]
9. Oridonin: a small molecule inhibitor of cystic fibrosis transmembrane conductance regulator (CFTR) isolated from traditional Chinese medicine.
Luan J; Zhang Y; Yang S; Wang X; Yu B; Yang H
Fitoterapia; 2015 Jan; 100():88-94. PubMed ID: 25447156
[TBL] [Abstract][Full Text] [Related]
10. Production of oridonin-rich extracts from Rabdosia rubescens using hyphenated ultrasound-assisted supercritical carbon dioxide extraction.
Yang YC; Lin PH; Wei MC
J Sci Food Agric; 2017 Aug; 97(10):3323-3332. PubMed ID: 27981601
[TBL] [Abstract][Full Text] [Related]
11. [Determination of oridonin and rosemarinic acid in Rabdosia rubescens by HPLC].
Wang K; Zhang ZQ
Zhong Yao Cai; 2007 Nov; 30(11):1396-8. PubMed ID: 18323207
[TBL] [Abstract][Full Text] [Related]
12. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells.
Ikezoe T; Chen SS; Tong XJ; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Oct; 23(4):1187-93. PubMed ID: 12964003
[TBL] [Abstract][Full Text] [Related]
13. Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES.
Meade-Tollin LC; Wijeratne EM; Cooper D; Guild M; Jon E; Fritz A; Zhou GX; Whitesell L; Liang JY; Gunatilaka AA
J Nat Prod; 2004 Jan; 67(1):2-4. PubMed ID: 14738375
[TBL] [Abstract][Full Text] [Related]
14. Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway.
Li X; Chen W; Liu K; Zhang S; Yang R; Liu K; Li D; Huang Y
Cancer Manag Res; 2020; 12():8081-8091. PubMed ID: 32982405
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells.
Kang N; Cao SJ; Zhou Y; He H; Tashiro S; Onodera S; Qiu F; Ikejima T
Int J Oncol; 2015 Dec; 47(6):2045-56. PubMed ID: 26648189
[TBL] [Abstract][Full Text] [Related]
16. Isolation and purification of oridonin from Rabdosia rubescens using upright counter-current chromatography.
Lu Y; Sun C; Pan Y
J Sep Sci; 2006 Feb; 29(2):314-8. PubMed ID: 16524109
[TBL] [Abstract][Full Text] [Related]
17. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
Li F; Fan J; Wu Z; Liu RY; Guo L; Dong Z; Wang Z
Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360
[TBL] [Abstract][Full Text] [Related]
18. Oridonin Suppresses Proliferation of Human Ovarian Cancer Cells via Blockage of mTOR Signaling.
Xia R; Chen SX; Qin Q; Chen Y; Zhang WW; Zhu RR; Deng AM
Asian Pac J Cancer Prev; 2016; 17(2):667-71. PubMed ID: 26925661
[TBL] [Abstract][Full Text] [Related]
19. A green approach for the extraction and characterization of oridonin and ursolic and oleanolic acids from Rabdosia rubescens and its kinetic behavior.
Yang YC; Wang CS; Wei MC
Food Chem; 2020 Jul; 319():126582. PubMed ID: 32199144
[TBL] [Abstract][Full Text] [Related]
20. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
